Sree Rama Bio-Sciences Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 24-05-2024
- Paid Up Capital ₹ 1.99 M
as on 24-05-2024
- Company Age 23 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -9.14%
(FY 2022)
- Profit -24041.97%
(FY 2022)
- Ebitda 15.81%
(FY 2022)
- Net Worth -12.54%
(FY 2022)
- Total Assets -1.26%
(FY 2022)
About Sree Rama Bio-Sciences
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.99 M, as per Ministry of Corporate Affairs (MCA) records.
Sreeja Subash and Subash Gopalakrishnan serve as directors at the Company.
- CIN/LLPIN
U24239KA2001PTC029410
- Company No.
029410
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Aug 2001
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sree Rama Bio-Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subash Gopalakrishnan  | Managing Director | 16-Aug-2001 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sreeja Subash | Whole-Time Director | 27-Sep-2012 | Current |
Financial Performance and Corporate Structure Insights of Sree Rama Bio-Sciences.
Sree Rama Bio-Sciences Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 9.14% decrease. The company also saw a substantial fall in profitability, with a 24041.97% decrease in profit. The company's net worth observed a substantial decline by a decrease of 12.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sree Rama Bio-Sciences?
In 2017, Sree Rama Bio-Sciences had a promoter holding of 54.58% and a public holding of 45.42%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vaidya Life Sciences Private LimitedActive 15 years 10 monthsSreeja Subash and Subash Gopalakrishnan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sree Rama Bio-Sciences?
Unlock and access historical data on people associated with Sree Rama Bio-Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sree Rama Bio-Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sree Rama Bio-Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
